
Loading, please wait...

Loading, please wait...

Uterine fibroids and infertility frequently coexist, creating significant challenges for women desiring pregnancy. These benign tumors impact reproductive outcomes through various mechanical and molecular mechanisms. Specifically, the location of the fibroid determines its clinical significance. While subserosal fibroids generally have minimal impact, intramural and submucosal types often impair conception. Consequently, clinicians must accurately classify these lesions to provide optimal care.
Surgical management remains the gold standard for FIGO Type 0, 1, 2, and 3 fibroids in women seeking to conceive. Furthermore, myomectomy offers better fertility outcomes compared to non-invasive alternatives. Notably, medical experts do not recommend uterine artery embolization for patients prioritizing future fertility. This procedure may compromise ovarian reserve or uterine blood flow. Therefore, surgical intervention provides the most reliable pathway for restoring the uterine cavity.
Large fibroids can physically obstruct the ovaries. This displacement makes transvaginal oocyte pick-up exceptionally difficult for fertility specialists. In such cases, surgeons should consider myomectomy prior to starting assisted reproduction cycles. Additionally, if the surgeon opens the uterine cavity during myomectomy, the patient must deliver via Cesarean section. This precaution prevents uterine rupture during future labor. Ultimately, personalized surgical planning ensures the safety of both the mother and the infant.
Submucosal fibroids (FIGO Types 0-2) have the most significant negative impact because they distort the uterine cavity. They reduce implantation rates and increase the risk of miscarriage.
No, uterine artery embolization is generally not recommended for women desiring pregnancy. Surgical myomectomy remains the preferred treatment to preserve uterine integrity and ovarian function.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Mocanu E et al. Fibroids and infertility. Int J Gynaecol Obstet. 2026 May 09. doi: 10.1002/ijgo.71062. PMID: 42104843.
2. Practice Committee of the American Society for Reproductive Medicine. Uterine myomas and infertility: a guideline. Fertil Steril. 2026.
3. Munro MG et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding. Int J Gynaecol Obstet. 2011;113(1):3-13.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Explore the impact of uterine fibroids on pregnancy and why surgical myomectomy remains the gold standard for fertility restoration over non-invasive method...
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today